[Mifepristone for induction of labor]

Area of Science:

• Obstetrics and Gynecology
• Pharmacology
• Reproductive Medicine

Background:

• Labor induction is a common obstetric procedure.
• Cervical ripening is crucial for successful labor induction.
• Mifepristone, an antiprogestin, has shown potential in cervical ripening.

Purpose of the Study:

• To evaluate the efficacy of mifepristone for pre-labor induction cervical ripening.
• To assess the safety of mifepristone for both mother and fetus during labor induction.
• To compare labor induction outcomes between mifepristone pretreatment and standard methods.

Main Methods:

• A randomized controlled trial involving 124 nulliparous women at 37-42 weeks gestation.
• Group A received mifepristone (50 mg q.12.h. for 2 days) followed by labor induction agents.
• Group B received standard labor induction agents without mifepristone pretreatment.

Main Results:

• Mifepristone significantly increased cervical Bishop score compared to controls.
• Spontaneous delivery rates were higher in the mifepristone group (22.58% vs. 4.84%).
• Lower oxytocin doses were required with higher success rates in the mifepristone group; side effects were mild.

Conclusions:

• Mifepristone is an effective agent for cervical ripening and labor induction in term pregnancy.
• Pre-induction administration of mifepristone can improve labor induction outcomes.
• Mifepristone demonstrates a favorable safety profile for mother and fetus in this context.